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Objective: To evaluate the antioxidant and antiproliferative effect of methanolic bee
pollen extract (BPE) of Malaysian stingless bee [Lepidotrigona terminata (L. terminata)]
and its synergistic effect with cisplatin (a chemotherapeutic drug) on MCF-7 cancer cell
line.
Methods: The antioxidant activity of BPE from L. terminata was measured by using
1,1-diphenyl-2-picrylhydrazyl radical (DPPH) assay. Antiproliferative activity at
different concentrations of BPE and cisplatin was determined through using MTT assay
on MCF-7 and L929 cell lines. An interaction effect (synergistic, additive and antag-
onistic) between BPE and cisplatin was determined by CompuSyn software based on
MTT assay data.
Results: The EC50 (50% decrement of DPPH inhibition) of BPE was 0.5 mg/mL.
L. terminata BPE exhibited antiproliferative activity on both cancer and normal cell lines.
The IC50 (concentration of drug that was required for 50% of cell inhibition in vitro) of
BPE on MCF-7 was 15 mg/mL whereas in normal cell line L929 was 26 mg/mL. The
IC50 for cisplatin on MCF-7 was 20 mmol/L. The combination effect of BPE and cisplatin
on MCF-7 cells showed that BPE at 15 mg/mL was able to potentiate the inhibitory effect
of cisplatin at all different concentrations (2.5–20.0 mg/mL). The average of cancer cells
inhibition which was potentiated by BPE was around 50%. A combination index values
of less than 1 reported in the CompuSyn software further proved the synergistic effect
between BPE and cisplatin, suggesting that BPE was working synergistically with
cisplatin.
Conclusions: Our study therefore suggested that BPE of Malaysian stingless bee,
L. terminata is a potential chemopreventive agent and can be used as a supplementary
treatment for chemotherapy drugs. BPE might be able to be used to potentiate the effect
of chemotherapy drugs with the possibility to reduce the required dose of the drugs. The
molecular mechanisms of how the BPE exerts antiproliferative activity will be a much
interesting area to look for in future studies.1. Introduction
Bee pollen is considered as a functional food due to its
compositions of carbohydrates, proteins, amino acids, lipids,sugars, ﬁbers, vitamins and mineral salts [1,2]. It is a collection of
pollen grains collected by the bees from various botanical
sources, mixed with nectar and secretion from the
hypopharyngeal glands such as b-glycosidase enzymes. Its
beneﬁcial effect on health is due to the presence of phenolic
compounds with high antioxidant activities [1,3].
Oxidative damage and carcinogenesis may gradually lead to
the formation of tumors through several mechanisms. Poly-
phenols present in bee pollen and other bee products contain
antioxidant and antiproliferative activities that can regulate cell
proliferation and induce apoptosis [4]. Bee pollen has the
antioxidative capacity and the ability to neutralize active
oxygen species, extensively due to the action of polyphenolse under the CC BY-NC-ND license (http://
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can inhibit tumor growth and alleviate the pain of chemotherapy
in cancer patients [5,6].
In China, bee pollen of Brassica campestris L.
(B. campestris) has been widely used as food supplement to
strengthen body resistance against cancer [7]. A steroid fraction
of bee pollen chloroform extract of B. campestris was shown
to strongly induce apoptosis in human prostate cancer PC-
3 cells [7]. A study by Izuta et al. showed that bee pollen was
able to suppress cells proliferation in in vitro model of
vascular endothelial growth factor-induced human umbilical
vein endothelial cells proliferation and migration [8].
Constituents of bee pollen such as polysaccharides were also
shown by Wang et al. to have signiﬁcant antiproliferative
activity in colon cancer cell lines [5]. Thus the aim of the
study is to evaluate the antiproliferative activity of bee pollen
extract (BPE) from Malaysian stingless bee, Lepidotrigona
terminata (L. terminata) and its effect when combined with
cisplatin on MCF-7 cancer cell lines.
2. Materials and methods
2.1. Samples and reagents
Bee pollen or bee bread sample was acquired from a local
stingless bee company, K.B meliponini. The source of bee
pollen was from the species of L. terminata. The species was
identiﬁed by the Entomology Section, Malaysian Agriculture
and Research Development Institute, Serdang, Malaysia. Bee
pollen sample was dried at 37 C for two consecutive days and
once dried, was kept at 4 C until further use.
2.2. Bee pollen crude extract
The crude BPE was prepared by using modiﬁed method from
LeBlanc et al. by extracting 10 g of bee pollen in 25 mL of
100% methanol [9]. The mixture was vortexed for 10 min and
sonicated for 1 h at 41 C before kept overnight at 4 C. The
mixture was then centrifuged at 6000 r/min for 10 min and
the precipitation was discarded. The supernatant was ﬁltered
by using a 0.2 mm sterile ﬁlter unit (Millipore, USA). Once
ﬁltered, it was dried in the rotary evaporator at 41 C and
freeze dried. The freeze dried BPE was kept at 4 C until
further analysis.
2.3. Antioxidant activity
The free radical-scavenging capacity of bee pollen meth-
anolic extract was determined by its ability to bleach the stable
1,1-diphenyl-2-picrylhydrazyl radical (DPPH) and was
expressed as the percentage of its neutralization. A modiﬁcation
of a method reported by Baharum et al. was employed [10]. The
reaction mixture contained 150 mL of DPPH (600 mmol/L) with
7.5 mL of different concentrations of BPEs (3.125, 6.250,
12.500, 25.000, 50.000 and 100.000 mg/mL). The ﬁnal
concentrations of bee pollen were 0.15, 0.30, 0.60, 1.20, 2.40
and 4.80 mg/mL. After 30 min at room temperature, the
reaction mixture was measured by the absorbance at
l = 517 nm. Trolox, a water-soluble derivative of vitamin E at
concentration of 25–600 mmol/L, was used as standard. DPPHfree radical scavenging activity was calculated through using
the following formula:
%Scavenging
=
Absorbance of control−Absorbance of test sample
Absorbance of control
× 100
2.4. Cell culture
MCF-7 and L929 cell lines used in this study were obtained
from the Advanced Medical and Dental Institute, Universiti
Sains Malaysia. The cell lines were cultured in a complete
Dulbecco's modiﬁed Eagle's medium (DMEM) containing
4 mmol/L L-alanyl-glutamine (GlutaMAX™) and supplemented
with 10% (v/v) fetal bovine serum, 100 IU/mL of penicillin and
0.1 mg/mL of streptomycin. The cells were grown in humidiﬁed
atmosphere under the conditions of 37 C with 5% (v/v) CO2.
2.5. Cell counts
MCF-7 and L929 cells were harvested by removing the
medium, washed with phosphate buffer saline (pH 7.45 without
Ca2+ and Mg2+) and then incubated with 1 mL of 0.25% trypsin
for 2 min. The ﬂask was gently tapped to detach them from the
plastic surface. Five milliliters of medium was added to the cell
suspension while the remaining cells were vigorously washed
from the bottom of the culture vessel. The suspended cells were
then collected in a 15 mL centrifuge tube and an aliquot of
10 mL was taken out prior centrifugation for cell count by using
hemocytometer. The number of cells per milliliter and the total
cell number were calculated. Subsequently after centrifugation,
an appropriate volume of complete medium was added to the
cell pellet.
2.6. Preparation of compound treatments
BPE stock solution (100 mg/mL) was prepared by diluting
0.1 g of crude extracts in 1 mL DMEM. The solution was then
ﬁltered by using a 0.2 mL sterile ﬁlter unit (Millipore, USA) and
diluted with culture medium to the ﬁnal concentration of 2.5 mg/
mL, 5 mg/mL, 10 mg/mL, 20 mg/mL and 40 mg/mL for
treatments.
Cisplatin stock solution (10 mol/L) was prepared by dis-
solving 6 mg of cisplatin (molecular weight = 300.01 g/moL) in
2 mL DMEM. The stock solution was then diluted with culture
medium to the ﬁnal concentration of 2.5 mmol/L, 5 mmol/L,
10 mmol/L, 20 mmol/L and 40 mmol/L for treatments. The
working solutions of the drug were freshly prepared prior
usage.
2.7. Cytotoxicity determination by using MTT assay
Brieﬂy, the cells were seeded at density of 1 × 104 cells per
well of ﬂat-bottomed 96-well microplate. The cells were incu-
bated at 37 C in a humidiﬁed 5% (v/v) CO2 for 24 h to let the
cells attach to the bottom of each well. The cultured cells were
then treated with different concentrations of BPE and cisplatin,
alone and with combination when the cells reached 70%
conﬂuence.
Figure 1. Scavenging effect of methanolic extract from L. terminata BPE
at different concentrations (0.15, 0.3, 0.6, 1.2, 2.4 and 4.8 mg/mL) on the
stable DPPH.
Results were expressed as percentage of DPPH inhibition with respect to
control; Each value represents the mean ± SD.
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(2.5, 5.0, 10.0, 20.0 and 40.0 mg/mL) and 5 different concen-
trations of cisplatin (2.5, 5.0, 10.0, 20.0 and 40.0 mmol/L). A
total of 200 mL of medium containing compound treatments was
added into each well. Treatments were carried out in triplicate.
Well with only treatment solution (either BPE or cisplatin) was
used as blank or background control, whereas well containing
cells without treatment was used as negative control. Once
treated, cells were incubated for 48 h.
The percentage of cell proliferation was determined by using
MTT assay with the Vybrant® MTT cell proliferation assay kit
(Thermo Fisher Scientiﬁc, USA). In brief, the fresh medium was
replaced after 48 h of incubation. Ten microliters of the
12 mmol/L MTT stock solution were added into each well. The
cells with MTT solution were incubated in the CO2 incubator for
4 h. The medium was then removed from the well after the cells
were labeled with MTT. DMSO (50 mL) was added to each well
and mixed thoroughly with a pipette. The plate was incubated
again at 37 C for 10 min. Finally the absorbance was read at
540 nm. The percentage of cell proliferation was calculated by
using the formula below:
%Cell proliferation
=
Absorbance sample−Absorbance blank
Absorbance negative control −Absorbance blank
× 100
2.8. Analysis of synergistic effects
To determine the synergistic, additive or antagonistic effect,
experiment with non-constant combination of BPE and cisplatin
concentrations was done following the method by Qiao et al.
with some modiﬁcations [11]. The cells were treated with
cisplatin at concentrations of 2.5, 5.0, 10.0, 15.0, 20.0 mmol/L
in combination with ﬁxed concentration of IC50 of BPE at
15 mg/mL. The data from this experiment were analyzed
through using CompuSyn software to determine the
synergistic, additive and antagonistic effect of the drugs
combination. The statistical analysis was performed and the
result was presented as combination index (CI). A CI value is
a mathematical and quantitative representation of the
pharmacological interplay of two drugs (CI > 1: antagonism;
CI = 1: additive; CI < 1: synergism) [12].
2.9. Statistical analysis
All values were expressed as the mean ± SD. The differences
in the mean of treated and untreated cells were analyzed by
using IBM SPSS Statistics 22 (US).
3. Results
3.1. Antioxidant capacity of BPE
In this study, the antioxidant activity of methanolic crude
extract of L. terminata BPE measured by using DPPH assay
showed a concentration dependent manner in the dose response
curve (Figure 1). The EC50 (50% decrement of DPPH inhibition)
of BPE was 0.5 mg/mL.3.2. Antiproliferative effect in vitro
The potential antiproliferative effect of BPE was assayed by
using the surrogate cell viability MTT assay. Crude BPE was
shown to inhibit the growth of both cancer and normal cell lines.
The inhibition of cell growth on the breast cancer MCF-7 and
normal L929 cell lines by BPE of L. terminata was in dose-
dependent manner (Figure 2). The IC50 of BPE on MCF-7
was 15 mg/mL, whereas in normal cell line was 26 mg/mL.
BPE at 20 mg/mL inhibited 70% of cell viability in the MCF-7
cells (Figure 2A) whereas in normal L929 cell lines, inhibition
of 70% of cell viability was observed with much higher con-
centration of 40 mg/mL (Figure 2B).
3.3. Cytotoxic synergism of BPE with chemotherapy
drug
To determine the combination effect of BPE and cisplatin (an
anticancer chemotherapy drug), we have designed a non-
constant combination treatment of cisplatin and BPE on MCF-
7 cells. Serial concentrations of cisplatin were combined with
the ﬁxed concentration of BPE at 15 mg/mL. Higher MCF-
7 cells inhibition was seen in BPE (15 mg/mL) and cisplatin at
all concentrations when compared to cisplatin alone. BPE
combination with 2.5 mmol/L cisplatin inhibited 55% of MCF-
7 cells proliferation when compared with 2.5 mmol/L cisplatin
alone. Whereas BPE in combination with 20 mmol/L cisplatin
could further reduce cell proliferation up to 76% compared to
52% reduction seen in treatment of 20 mmol/L cisplatin alone,
although it was not statistically signiﬁcant. The result showed
that the BPE was able to potentiate the inhibitory effect of
cisplatin in breast cancer cells when combined with cisplatin at
all concentrations (Figure 3).
To further conﬁrm the interaction between cisplatin and BPE,
the data was computed in CompuSyn software. CI values of less
than 1 were seen in all interactions between BPE and cisplatin.
Reported results in the CompuSyn software were between 0.46
and 0.97 (Table 1). The lowest CI value was seen in combina-
tion of BPE and cisplatin at 10.0 mmol/L dose.
Figure 2. Antiproliferative effect of BPE at different concentrations on MCF-7 cell lines and L929 cell lines.
A: MCF-7 cell lines; B: L929 cell lines; Each value represents the mean ± SD from three separate experiments.
Figure 3. The effect of cisplatin alone and combination of cisplatin and
BPE on MCF-7 cells.
The percentage of cell proliferation was measured at 48 h post-treatment;
Each value represents the mean ± SD from three separate experiments;
Statistical analysis was determined by using student's t-test with **:
P < 0.001; *: P < 0.05.
Table 1
CI data for combination effect of cisplatin and BPE on MCF-7 cells.
Cisplatin dose (mmol/L) BPE dose (mg/mL) Effect CI
2.5 15.0 0.4541 0.9706
5.0 15.0 0.4115 0.9472
10.0 15.0 0.2893 0.4632
15.0 15.0 0.2652 0.8495
20.0 15.0 0.2360 0.9057
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Our study showed that the antioxidant activity of
L. terminata BPE exhibited much higher percentage of DPPH
inhibition than other Malaysian stingless bee species reported
recently. BPE from species Trigona apicalis and Trigona itama
at concentration of 1 mg/mL showed 39% and 19% of DPPH
inhibition, respectively, compared to 70% DPPH inhibition of
1 mg/mL methanolic BPE from L. terminata [13]. However, the
result of this study showed lower inhibition than that of Silva
et al. which reported that crude BPE from the Brazilian
stingless bee species Melipona ruﬁventris at concentration
0.1 mg/mL was shown to exhibit 50% DPPH inhibition [14].
The difference in antioxidant activity seen in our study could
be due to the difference of the solvent used (methanol in thisstudy vs. ethanol in the study by Silva et al.), which may give
different compounds extraction efﬁcacy, therefore contributed to
the different chemical activities [14,15]. Furthermore speciﬁc
pollen foraging activities, different pollen species and different
diets of stingless bee itself may give different compounds
activities found in BPE [14,16]. Previous studies have shown
that bee pollen has good antioxidant properties related to the
presence of phenolic compounds [2,17].
The antiproliferative activity of L. terminata BPE against
MCF-7 and L929 cell lines was evaluated by using MTT assay.
The concentration of BPE required to inhibit 50% of MCF-
7 cells growth was 15 mg/mL. At 20.0 mg/mL, 70% inhibition
of MCF-7 cells was seen. Whereas in normal L929 cell line,
26 mg/mL was required to exhibit 50% cells inhibition. The
response different between normal and cancer cells may suggest
that BPE can be relatively safe in normal cells and considered to
be a useful agent for anticancer application in future. The much
lower IC50 of BPE in cancer cells suggests that BPE may be
speciﬁcally targeting the MCF-7 cancer cells.
Similar antiproliferative effect of BPE had been reported in
the study by Kustiawan et al. by using four stingless bee species
[18]. The result revealed that all four species were cytotoxic to
different cell lines tested although their antiproliferative
activities were rather low compared to the chemotherapeutic
drugs used. Another study by Wu and Lou also showed strong
antiproliferative activity of B. campestris bee pollen
chloroform extract in inducing apoptosis in human prostate
cancer [7]. The observed cytotoxic activity exhibited by bee
pollen varied with the different solvent used, bee species and
different cell lines.
In cytotoxic synergism assay, the average of MCF-7 cells
inhibition by BPE in combination of cisplatin was around 50%.
This study shows that BPE is able to potentiate and enhance the
cisplatin effect on MCF-7 cells at all concentrations.
Active compounds in the BPE might either enhance (syner-
gistic) or decrease (antagonistic) the therapeutic activity of
chemotherapy drugs. There was a great concern that some
compounds present in the natural product might work antago-
nistically instead of synergistically with the therapeutic activity
of drugs [19]. In this study, CI values reported in all interactions
between BPE and cisplatin were less than 1. These CI values
further proved the synergistic effect between the two compounds.
This study may suggest that BPE from Malaysian stingless
bee L. terminata can be used to supplement the chemothera-
peutic agents due to its antiproliferative activity and its ability to
enhance the effect of chemotherapy agent, even at low con-
centration. In a recent review by Komosinska-Vassev et al., bee
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prostate cancer when given together with chemotherapeutic drug
[20]. Furthermore, bee pollen as supplement can be combined
with chemotherapy treatment to treat side effects of cancer as
reported in a recent study by Salles et al. which showed that
bee pollen was able to improve muscle mass and metabolism
in undernourished rats [21]. Decreasing muscle mass and poor
metabolisms were commonly seen in patients with cancer [22].
The combination of chemotherapy drug and natural product
such as BPE may be potentially effective in cancer treatment
in future.
The data of this study suggest that bee pollen extract of
Malaysian stingless bee is a potential chemopreventive agent
and can be used as a supplement during chemotherapy treat-
ment. The same data indicate that BPE works synergistically
with chemotherapy drug, cisplatin and enhances the effect of
cisplatin even at lower concentration. The molecular mecha-
nisms of how the BPE exerts its antiproliferative and synergistic
activities with cisplatin will be a promising area to further
explore in future studies.
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